Meet Our Scientific and Clinical Advisors
These highly-regarded global experts in infectious disease, immuno-oncology, and vaccine development help guide the advancement and direction of our pipeline programs.
Michel De Wilde, Ph.D.
Director, Chair of Scientific and Clinical Advisory Boards
Hepatitis B Virus (HBV)
Adam Finn, M.D., Ph.D.
Peter A. Patriarca, M.D.
Daniel Shouval, M.D.
Bruce Smith, Ph.D.
Stefan Thoelen, M.D.
Pierre Van Damme, M.D., Ph.D.
Glioblastoma (GBM)
Denis R. Burger, Ph.D.
Michael Lim, M.D.
Allen Waziri, M.D.
Patrick Yung Wen, M.D.
Cytomegalovirus (CMV)
Robert Pass, M.D.
Stanley Plotkin, M.D.